We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+14.99%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$14.3M
Cap. Flow
-$7.62M
Cap. Flow %
-2.81%
Top 10 Hldgs %
44.18%
Holding
263
New
80
Increased
53
Reduced
58
Closed
71

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$2M
2
MDLZ icon
Mondelez International
MDLZ
+$1.95M
3
AXP icon
American Express
AXP
+$1.74M
4
CI icon
Cigna
CI
+$1.2M
5
ELV icon
Elevance Health
ELV
+$1.08M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$2.59M
2
CSCO icon
Cisco
CSCO
+$2.43M
3
CVX icon
Chevron
CVX
+$2.42M
4
EOG icon
EOG Resources
EOG
+$2.4M
5
KO icon
Coca-Cola
KO
+$1.86M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Financials 12.76%
3 Healthcare 10.96%
4 Industrials 6.05%
5 Consumer Discretionary 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCAR icon
76
PACCAR
PCAR
$69.8B
$790K 0.29%
+6,380
New +$686K
WDAY icon
77
Workday
WDAY
$44.8B
$785K 0.29%
+2,877
New +$819K
COST icon
78
Costco
COST
$419B
$775K 0.29%
+1,058
New +$755K
QCOM icon
79
Qualcomm
QCOM
$171B
$771K 0.28%
+4,553
New +$704K
ALNY icon
80
Alnylam Pharmaceuticals
ALNY
$29.6B
$767K 0.28%
5,129
+409
+9% +$68.2K
APP icon
81
Applovin
APP
$107B
$764K 0.28%
11,031
-4,192
-28% -$222K
NOW icon
82
ServiceNow
NOW
$132B
$756K 0.28%
+4,960
New +$751K
KLAC icon
83
KLA
KLAC
$262B
$756K 0.28%
10,820
-13,280
-55% -$853K
PSX icon
84
Phillips 66
PSX
$89.5B
$740K 0.27%
4,533
+1,232
+37% +$178K
LRCX icon
85
Lam Research
LRCX
$390B
$712K 0.26%
+7,330
New +$645K
DKS icon
86
Dick's Sporting Goods
DKS
$18.4B
$701K 0.26%
+3,116
New +$532K
SLM icon
87
SLM Corp
SLM
$5.11B
$651K 0.24%
+29,874
New +$596K
AEO icon
88
American Eagle Outfitters
AEO
$2.91B
$651K 0.24%
+25,223
New +$560K
PCOR icon
89
Procore
PCOR
$8.93B
$648K 0.24%
+7,880
New +$585K
TMHC
90
DELISTED
Taylor Morrison
TMHC
$644K 0.24%
+10,354
New +$570K
EHC icon
91
Encompass Health
EHC
$12.4B
$639K 0.24%
+7,738
New +$567K
WSFS icon
92
WSFS Financial
WSFS
$4.14B
$637K 0.24%
+14,103
New +$614K
AZEK
93
DELISTED
The AZEK Co
AZEK
$632K 0.23%
+12,594
New +$549K
BILL icon
94
BILL Holdings
BILL
$4.93B
$631K 0.23%
+9,175
New +$641K
SPYG icon
95
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.9B
$628K 0.23%
+8,587
New +$598K
PSN icon
96
Parsons
PSN
$5.15B
$621K 0.23%
7,483
-1,851
-20% -$135K
BOKF icon
97
BOK Financial
BOKF
$8.75B
$617K 0.23%
+6,708
New +$569K
SRCE icon
98
1st Source
SRCE
$2.12B
$616K 0.23%
+11,742
New +$602K
RXST icon
99
RxSight
RXST
$293M
$608K 0.22%
11,782
-1,383
-11% -$67.9K
DHI icon
100
D.R. Horton
DHI
$42.2B
$608K 0.22%
3,693
-85
-2% -$12.7K

Similar funds

Alpha DNA Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Alpha DNA Investment Management held 263 positions worth $271M, up 5.6% from $256M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Alpha DNA Investment Management's Q1 2024 filing shows 80 new, 53 increased, 58 reduced and 71 closed positions. Its largest new stake was American Express: 8,386 shares worth $1.91M. The largest sale was Wells Fargo, an estimated $2.59M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Alpha DNA Investment Management's largest Q1 2024 buy was American Express: 8,386 shares worth $1.91M.
  • Alpha DNA Investment Management added most to McDonald's in Q1 2024, an estimated $2M increase.
  • Alpha DNA Investment Management's biggest Q1 2024 reduction was Wells Fargo, cutting an estimated $2.59M.
  • Alpha DNA Investment Management fully exited Coca-Cola in Q1 2024, selling an estimated $1.86M.
  • Alpha DNA Investment Management's ten largest holdings make up 44% of its $271M portfolio in Q1 2024.
  • Alpha DNA Investment Management opened 80 new positions and closed 71 in Q1 2024.
  • Alpha DNA Investment Management's portfolio value rose 5.6% quarter-over-quarter to $271M.

Based on Alpha DNA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.